Demographic details of lung allograft recipients
| Subject | S100A4 (% epithelia)* | Age at transplant(years) | Sex | Pretransplant diagnosis | Operation | Time after operation (months) | BOS stage† | TBBX‡ |
|---|---|---|---|---|---|---|---|---|
| CF, cystic fibrosis; CFA, cryptogenic fibrosing alvolitis; RA, rheumatoid arthritis; SLT, single lung transplantation; BLT, double lung transplantation; BOS, bronchiolitis obliterans syndrome; TBBX, transbronchial biopsy. | ||||||||
| *S100A4 (% epithelia), % of biopsy epithelium stained for S100A4. | ||||||||
| †BOS stage: 0 = no BOS, 1 = FEV1.0 60–80% best after transplantation. | ||||||||
| ‡TBBX, transbronchial biopsy assessed by pathologist for rejection: a = acute rejection, ⩽a1 non-significant, b = airway assessment, axbx = no material for assessment. | ||||||||
| 1 | 7 | 39 | M | CF | BLT | 6 | 0 | a0b0 |
| 2 | 13 | 55 | F | CFA | SLT | 1 | 0 | a0b1 |
| 3 | 27 | 25 | F | CF | BLT | 3 | 0 | a1/2bx |
| 4 | 42 | 31 | F | CF | BLT | 12 | 0 | a1b1 |
| 5 | 0 | 37 | M | Emphysema | BLT | 6 | 0 | a1b1 |
| 6 | 8 | 32 | M | CF | BLT | 6 | 0 | a1/2 b1 |
| 7 | 32 | 49 | M | Emphysema | BLT | 3 | 0 | a1bx |
| 8 | 13 | 28 | M | CF | BLT | 3 | 0 | a1bx |
| 9 | 16 | 59 | F | Emphysema | SLT | 12 | 0 | a0b0 |
| 10 | 48 | 40 | M | Fibrosis (RA) | SLT | 12 | 0 | a0bx |
| Cultures | ||||||||
| 1 | – | 39 | M | CF | BLT | 6 | 0 | a0b0 |
| 9 | – | 59 | F | Emphysema | SLT | 12 | 0 | a0b0 |
| 11 | – | 28 | F | CF | BLT | 6 | 0 | a0bx |
| 12 | – | 51 | F | Emphysema | BLT | 6 | 0 | a0b0 |
| 13 | – | 47 | F | Emphysema | SLT | 12 | 0 | a1b0 |
| 14 | – | 49 | F | Emphysema | SLT | 12 | 0 | a1bx |
| 15 | – | 22 | F | CF | BLT | 7 | 0 | axbx |
| 16 | – | 23 | M | CF | BLT | 1 | 1 | a0b0 |